Reading a Peptide HPLC Trace — A 5-Minute Field Guide for Bench Scientists. Read our briefing →
Reading a peptide HPLC trace — a field guide. Read →
On reading HPLC traces. Read →
Reference-name product · composition confirmed per batch COA
Overview
Klow is a reference-name product that appears in upstream price tables under a commercial brand designation rather than a publicly defined chemical name. As with the other reference-name preparations in the catalogue, the trade name alone is not an identity statement: the actual API composition, any peptide sequence, and CAS designation are confirmed against the batch-specific Certificate of Analysis before order placement and again at receipt. Lyochem lists Klow to support research-buyer workflows that reference these upstream codes; the per-lot COA's component-level analysis is the operative document for any downstream research or quality work. Direct end-buyers should request explicit composition disclosure from the regulatory team before ordering rather than treating the brand name as sufficient. When a reference-name lot is released, the documentation reflects the verified composition as released, with the standard analytical scope applied to the dominant species — RP-HPLC purity, mass-spec confirmation, counter-ion, and water content by Karl Fischer. Confirm API by COA / label before use. This is reference-grade research material, distinct from compounding-scale API supply.
Applications & buyer fit
Other research peptides in this category — Melanotan-1, Melanotan-2, PT-141, ACE-031, Adipotide-FTTP, EPO, HCG, HMG — ship to research labs studying topics outside the GH / cognitive / immune / mitochondrial / repair / longevity / Khavinson clusters. Each peptide has its own analytical-packet emphasis (e.g. glycoprotein bioassay in IU/mg for HCG; cyclised-form confirmation for oxytocin) noted in the per-product CoA scope.
Contract Research Organisations (CROs)
CROs running preclinical and translational studies on behalf of academic, biotech, or pharma sponsors who need traceable reference material across multi-site campaigns.
Biotech R&D Groups
Preclinical biotech and pharmaceutical discovery teams sourcing characterized peptides for receptor-pharmacology, screening, and method-development campaigns.
Every release ships with its own batch-specific CoA — identity, purity, and the analytical scope agreed at quote stage, tied to the exact lot you receive.
Review a representative batch CoA before you order, so you can confirm the packet matches what your method or sponsor audit needs.
Supplied strictly as a research reagent to research institutions — not a finished dosage form and not for human administration. Buyer qualification runs at the inquiry stage.
Specifications
Documentation available on request
Regulatory note
Reference-name product without a publicly disclosed API identity; composition is confirmed on the batch-specific COA before any downstream research use. Confirm API by COA / label before use. Sold for Research Use Only under the receiving laboratory's institutional and jurisdictional regulations.
Frequently asked questions
Klow exists primarily to support buyers whose upstream procurement systems reference the commercial brand code. For most research the cleaner route is to identify the underlying API through Lyochem's regulatory-team disclosure and order the named-API standard instead, since the reference-name path adds catalog-level opacity and resolves identity only at the COA. Reserve the reference-name path for workflows that specifically require the brand designation.
Each lot ships with a batch-specific COA covering the verified composition as released, the RP-HPLC chromatogram for the released material, mass-spec data for the dominant species, water content by Karl Fischer, and microbial limits where the application requires them. The documentation specifies the verified composition without disclosing the upstream proprietary formulation; buyers needing full composition disclosure should request it explicitly at quote stage.
The 5 mg and 10 mg fills suit pilot-scale and standard aliquot work, while the 80 mg fill targets larger workflows. Fill-size choice is independent of identity confirmation, which is performed against the batch-specific COA at receipt; the underlying composition is the same across formats for a given released batch.
Related peptides